Cancer is an Insufficiently Recognized Risk Factor for Atrial Fibrillation

Koraćević, Goran

doi:10.1016/j.jemermed.2010.05.080

Cited by 3 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The remaining articles were screened, and 3487 were subsequently excluded because they were review articles, animal studies, or irrelevant to this analysis. The 28 remaining studies were then reviewed in detail, and 23 of the 28 were excluded: study published in Italian, Russian, or Spanish language ( n =5) [13–16]; study reported AF leading to cancer ( n =4) [17–20]; individual case reports ( n =3) [21–23]; letters [24, 25] or editorials [26] ( n =3); different article from the same center [27, 28], and a more recent series was available [8], patients in this study [29] may be repeated in the study by Conen [10] ( n =3); study evaluated the relation of AF and survival in cancer patients ( n =2) [30, 31]; OR was not provided ( n =1) [32]; cross-sectional study ( n =1) [33]; and study investigated AF as a complication in cancer patients ( n =1) [34]. Therefore, a total of five studies comprising 5,889,234 participants were included in our meta-analysis.…”

Section: Resultsmentioning

confidence: 99%

Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis

Yuan

Zhang

Tse

et al. 2019

Cardiology Research and Practice

View full text Add to dashboard Cite

Aims. Previous studies have demonstrated epidemiological evidence for an association between cancer and the development of new-onset atrial fibrillation (AF). However, these results have been conflicting. This systematic review and meta-analysis was conducted to examine the relationship between cancer and the risk of developing atrial fibrillation. Methods. PubMed and Web of Science were searched for publications examining the association between cancer and atrial fibrillation risk published until June 2017. Adjusted odds ratios (ORs) or hazard ratios (HRs) and 95% CI were extracted and pooled. Results. A total of five studies involving 5,889,234 subjects were included in this meta-analysis. Solid cancer patients are at higher risk developing atrial fibrillation compared to noncancer patients (OR 1.47, 95% CI 1.31 to 1.66, p<0.00001; I2 = 67%, p=0.02). The risk of atrial fibrillation was highest within 90 days of cancer diagnosis (OR 7.62, 95% CI 3.08 to 18.88, p<0.00001) and this risk diminished with time. Conclusions. The risk of AF was highest within 90 days of cancer diagnosis. We should take into account the increased risk of atrial fibrillation development and, after this, study the embolic risk and potential indication of oral anticoagulation.

show abstract

Section: Resultsmentioning

confidence: 99%

Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis

Yuan

Zhang

Tse

et al. 2019

Cardiology Research and Practice

View full text Add to dashboard Cite

show abstract

“…Several previous studies suggested that subjects with certain cardiovascular diseases, such as atrial fibrillation [18], heart failure [19], abdominal aortic aneurysm, and peripheral artery disease [20], may have a higher risk for GI malignancies, although, most of such observations had been derived from small-size samples, and thus did not seem to be conclusive. The association between cardiovascular diseases and GI malignancies, if present, may be attributed to share of common risk factors, alterations in the autonomic nervous system in cancer patients [21,22], and excessive blood loss leading to the aggravation of heart failure symptoms [23]. Of note, by performing screening colonoscopy after coronary angiography in more than 400 patients, Chan et al have shown that the prevalence of colorectal cancer in patients with CAD was unexpectedly high (4.4%), which contrasted with a much lower prevalence of such lesions (0.5%) in CAD-negative patients [16].…”

Section: Discussionmentioning

confidence: 99%

The prevalence of malignant neoplastic and non-malignant gastrointestinal lesions in cardiology inpatients

Sakamoto

Fujishiro

Koike

et al. 2013

Journal of Cardiology

View full text Add to dashboard Cite

show abstract

Less Known but Clinically Relevant Comorbidities of Atrial Fibrillation: A Narrative Review

Koraćević

Stojković

Stojanović³

et al. 2022

CVP

View full text Add to dashboard Cite

Background: The important risk factors for atrial fibrillation (AF) in the general population are not always equally important in specific and relatively prevalent diseases. Objective: The main goal of this narrative review is to focus attention on the presence and the relationship of AF with several important diseases, such as cancer or sepsis, in order to: 1) stimulate further research in the field, and 2) draw attention to this relationship and search for AF in clinical practice. Methods: We searched PubMed, SCOPUS, Elsevier, Wiley, Springer, Oxford Journals, Cambridge, SAGE, and Google Scholar for less-known comorbidities of AF. The search was limited to publications in English. No time limits were applied. Results: AF is widely represented in cardiovascular and other important diseases, even in those in which AF is rarely mentioned. In some specific clinical subsets of AF patients (e.g., patients with sepsis or cancer), the general risk factors for AF may not be so important. Patients with new-onset AF have a several-fold increase in relative risk of cancer, deep vein thrombosis, and pulmonary thromboembolism (PTE) during the follow-up. Conclusion: AF presence, prognosis, and optimal therapeutic approach are insufficiently recognised in several prevalent diseases, including life-threatening ones. There is a need for a better search for AF in PTE, pulmonary oedema, aortic dissection, sepsis, cancer and several gastrointestinal diseases. Improved AF detection would influence treatment and improve outcomes.

show abstract

Cancer is an Insufficiently Recognized Risk Factor for Atrial Fibrillation

Cited by 3 publications

References 9 publications

Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis

Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis

The prevalence of malignant neoplastic and non-malignant gastrointestinal lesions in cardiology inpatients

Less Known but Clinically Relevant Comorbidities of Atrial Fibrillation: A Narrative Review

Contact Info

Product

Resources

About